Variant report
Variant | esv3378197 |
---|---|
Chromosome Location | chr6:31221223-31228521 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:31209841..31212396-chr6:31219604..31221505,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574773987 | chr6:31227206-31227207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs189195118 | chr6:31227218-31227219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs9264327 | chr6:31227219-31227220 | Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
4 | rs150543164 | chr6:31227236-31227237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9264328 | chr6:31227250-31227251 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs9264329 | chr6:31227254-31227255 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs9264330 | chr6:31227263-31227264 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs181538866 | chr6:31227275-31227276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs529592501 | chr6:31227304-31227305 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs547833539 | chr6:31227306-31227307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569649393 | chr6:31227309-31227310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs370001105 | chr6:31227316-31227317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs76159976 | chr6:31227317-31227318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112985663 | chr6:31227321-31227322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs186534082 | chr6:31227339-31227340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs139410771 | chr6:31227344-31227345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs149950940 | chr6:31227346-31227347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs574604768 | chr6:31227387-31227388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558603725 | chr6:31227401-31227402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs41268872 | chr6:31227402-31227403 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs191392216 | chr6:31227403-31227404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs575738643 | chr6:31227455-31227456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546306836 | chr6:31227456-31227457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs9264333 | chr6:31227457-31227458 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs9264334 | chr6:31227475-31227476 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs9264335 | chr6:31227494-31227495 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs139968583 | chr6:31227496-31227497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs2853965 | chr6:31227505-31227506 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs9264337 | chr6:31227506-31227507 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs182814380 | chr6:31227534-31227535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112973824 | chr6:31227557-31227558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs556455964 | chr6:31227568-31227569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs9264338 | chr6:31227577-31227578 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs9264339 | chr6:31227588-31227589 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs534422439 | chr6:31227626-31227627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs28749575 | chr6:31227639-31227640 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs143021662 | chr6:31227649-31227650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs138594816 | chr6:31227650-31227651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557258376 | chr6:31227662-31227663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs569268553 | chr6:31227666-31227667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2524125 | chr6:31227667-31227668 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs141583429 | chr6:31227671-31227672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs201012238 | chr6:31227677-31227678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs145480498 | chr6:31227686-31227687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs540735294 | chr6:31227687-31227688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs137990055 | chr6:31227697-31227698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs9264341 | chr6:31227713-31227714 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs544561941 | chr6:31227726-31227727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562892446 | chr6:31227730-31227731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533449424 | chr6:31227733-31227734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Breast cancer | 21364760 | CNVD |
Systemic lupus erythematosus | 19279649 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Acute myocardial infarction | 18032375 | CNVD |
Renal cell carcinoma | 19150565 | CNVD |
Systemic lupus erythematosus | 19591781 | CNVD |
Attention deficit hyperactivity disorder | 19287146 | CNVD |
Autism | 19287146 | CNVD |
Erythema nodosum in leprosy | 19287146 | CNVD |
Henoch-schoenlein purpura | 19287146 | CNVD |
Liver cirrhosis | 19287146 | CNVD |
Systemic lupus erythematosus | 19287146 | CNVD |
Congenital adrenal hyperplasia | 18478071 | CNVD |
Systemic lupus erythematosus | 19287147 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:31227200-31228400 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
2 | chr6:31227200-31228800 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
3 | chr6:31227200-31228800 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |
4 | chr6:31227400-31228400 | Enhancers | Primary T cells fromperipheralblood | blood |
5 | chr6:31227600-31228200 | Enhancers | Primary B cells from peripheral blood | blood |
6 | chr6:31227600-31229200 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
7 | chr6:31227800-31228400 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
8 | chr6:31227800-31228400 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
9 | chr6:31227800-31228600 | Enhancers | Primary T helper cells fromperipheralblood | blood |
10 | chr6:31228000-31228200 | Enhancers | Fetal Thymus | thymus |
11 | chr6:31228000-31228400 | Enhancers | Primary T cells effector/memory enriched fromperipheralblood | blood |
12 | chr6:31228000-31228400 | Enhancers | Primary T killer memory cells from peripheral blood | blood |
13 | chr6:31228000-31228600 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
14 | chr6:31228000-31228800 | Enhancers | Primary T helper memory cells from peripheral blood 1 | blood |
15 | chr6:31228200-31235800 | Weak transcription | Fetal Thymus | thymus |
16 | chr6:31228400-31233800 | Weak transcription | Primary T cells fromperipheralblood | blood |
17 | chr6:31228400-31235400 | Weak transcription | Primary T helper memory cells from peripheral blood 2 | blood |